Income Statement
PERSPECTIVE THERAPEUTICS, INC.
CATX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Jun 30, 2022 2022 FY | Jun 30, 2021 2021 FY | Jun 30, 2020 2020 FY | Jun 30, 2019 2019 FY | Jun 30, 2018 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Jun 30, 2015 2015 FY | Jun 30, 2014 2014 FY | Jun 30, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | 5.92 | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | 6.18 | 4.93 | 4.56 | 4.27 | 4.08 | - | - | - | - | - |
|
Gross Profit
|
- | - | 1.43 | 4.62 | 5.12 | 5.12 | 3.05 | 1.84 | 0.84 | 0.13 | 0.17 | -0.20 | 0.15 |
|
Operating Expenses
|
114.45 | 92.34 | 42.38 | 12.01 | 8.57 | 8.60 | 8.30 | 8.57 | 7.15 | 5.21 | 4.50 | 4.39 | 4.22 |
|
Research & Development
|
84.22 | 41.64 | 21.31 | 2.58 | 1.43 | 1.13 | 1.47 | 1.75 | 0.97 | 0.53 | 0.61 | 0.67 | 0.63 |
|
Selling, General & Administrative
|
30.23 | 26.61 | 21.06 | 6.62 | 4.69 | 4.57 | 4.17 | 4.17 | 3.92 | 3.79 | 2.40 | 2.49 | 2.29 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-114.45 | -92.34 | -40.94 | -7.39 | -3.45 | -3.48 | -5.25 | -6.73 | -6.31 | -5.08 | -4.34 | -4.59 | -4.07 |
|
Non-Operating Income
|
9.14 | 10.46 | 0.84 | 0.12 | 0.06 | 0.03 | 0.11 | 0.03 | 0.15 | 0.37 | 0.66 | -1.37 | 0.21 |
|
Interest Income
|
8.11 | 10.52 | 0.93 | 0.12 | 0.06 | 0.03 | 0.11 | 0.03 | 0.12 | 0.22 | 0.28 | 0.01 | 0.00 |
|
Interest Expense
|
- | - | 0.08 | - | - | - | - | - | 0.00 | 0.00 | 0.00 | - | - |
|
Other Non-Op Income / Expense
|
0.00 | -0.01 | -0.02 | - | - | - | 0.00 | - | - | - | - | - | - |
|
Income Before Tax
|
-104.43 | -80.43 | -40.11 | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
-1.31 | -1.15 | 6.40 | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-103.12 | -79.28 | -46.51 | -7.27 | 3.39 | 3.45 | -5.14 | 6.70 | 0.00 | 0.00 | -3.68 | 5.96 | 3.86 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Jun 30, 2022 2022 FY | Jun 30, 2021 2021 FY | Jun 30, 2020 2020 FY | Jun 30, 2019 2019 FY | Jun 30, 2018 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Jun 30, 2015 2015 FY | Jun 30, 2014 2014 FY | Jun 30, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-111.20 | -90.03 | -40.94 | -7.39 | -3.45 | -3.48 | -5.25 | -6.73 | -6.24 | -4.61 | -3.76 | -3.90 | -3.33 |
|
Earnings Per Share (Basic)
|
-1.40 | -1.23 | -0.17 | -0.05 | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-1.40 | -1.23 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
73.81 | 64.43 | 267.64 | 141.99 | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
73.81 | 64.43 | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-102.96 | -79.33 | - | - | - | - | - | - | - | - | - | - | - |